Loading clinical trials...

Beauty Image Efficacy Study | Clinical Trials | Clareo Health

COMPLETEDNA

Beauty Image Efficacy Study

NCT04733755•Pharmanex

Summary

The objective is to evaluate the effects of oral supplement of a blend containing collagen peptides, phosphatidylserine, Saussurea involucrata and lutein (Beauty Image) on the improvement of skin aging in terms of hydration, gloss, melanin content, roughness and wrinkling, and anti-UV performance.

Eligibility

Age

28 - 55 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Facial skin with problems of dull, uneven, inelastic, dryness and wrinkle/fine line (At least fit to two problems)
•In general good health and good mental state;
•Willing to read, understand and able to sign the Informed Consent Form;
•Willing to comply with all study protocol requirements.

Exclusion Criteria

•Intention to become pregnant, pregnant, lactating or within 6 months of delivery;
•Participation in any clinical test or cosmetic product test on skin within 30 days;
•Existence of neurodermatitis, pityriasis, seborrheic dermatitis or psoriasis capitis on test area;
•Use of any anti-inflammatory drugs in the past 2 months;
•A history of skin diseases such as psoriasis, eczema, psoriasis, skin cancer, etc.;
•IDDM: Insulin dependent diabetic patients;
•Current treatment for asthma or other chronic respiratory diseases;
•Undergoing anticancer chemotherapy in the past 6 months;
•Existence of any other health problems or chronic diseases;
•Use of retinoids, alpha hydroxyl acid, ortho-hydroxybenzoic acid, hydroquinone nearly within 3 months; or use of prescriptions (such as antibiotics, retinoids, alpha hydroxyl acid or steroids), oral contraceptives (Use of same contraceptives for 6 months excepted);
+1 more criteria

Locations (1)

Nu Skin (China) Daily-use & Health Products CO., LTD

Shanghai, Shanghai Municipality, China

Key Dates

Start Date

May 1, 2018

Primary Completion Date

August 1, 2018

Completion Date

September 1, 2018

Last Updated

February 2, 2021

Enrollment

ACTUAL participants

Conditions

Skin Aging

Interventions

Beauty Image

DIETARY_SUPPLEMENT

Placebo Control

DIETARY_SUPPLEMENT

MENA Consensus on Poly-L-Lactic Acid (PLLA) Biostimulator Use in Aesthetic Dermatology

NCT07261748

Aesthetic ProceduresCosmetic Techniques+2 more

View study

ACTIVE_NOT_RECRUITINGNA

A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging

NCT06804759

Skin Aging

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 2, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Beauty Image Efficacy Study

Inclusion Criteria

Exclusion Criteria

MENA Consensus on Poly-L-Lactic Acid (PLLA) Biostimulator Use in Aesthetic Dermatology

A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging

Efficacy and Safety of NP-2007 on Skin Health

A Pilot Study to Evaluate the Expanded Reach of Decentralized Digital Skin Health Clinical Studies

A Clinical Study Testing How Well the Medical Device HTIC (a Type of Animal-derived Collagen) Works in Treating Skin Problems, Such as Scars, Loss of Firmness, and Volume in Certain Areas of the Face and Body

Efficacy Study of Oral Collagen Peptide on Skin Condition Improvement